Table 6.
Species | Categories | Year | Number of isolate | Reporting countries (N) | GEN | STR | CIP | ERY | TET | CIP/ERY | CS |
---|---|---|---|---|---|---|---|---|---|---|---|
C. jejuni | Broiler carcases | 2019 | 70 | HR, LU, NL, PT, RO (5) | 0.0 | 7.2 | 90.0 | 0.0 | 42.9 | 0.0 | 8.6 |
2020 | 361 | HR, DE, NL, RO (4) | 0.0 | 23.8 | 82.8 | 0.5 | 57.6 | 0.3 | 13.85 | ||
Fresh broiler meat | 2019 | 398 | AT, BE, DK, LU, NL, PT (6) | 0.0 | 8.3 | 68.6 | 0.25 | 44.1 | 0.25 | 30.10 | |
2020 | 343 | AT, BE, DE, LU, NL (5) | 0.0 | 22.2 | 74.9 | 0.0 | 58.6 | 0.0 | 21.9 | ||
Broiler meat preparations | 2019 | 53 | BE, LU, NL (3) | 0.0 | 15.1 | 64.2 | 0.0 | 52.8 | 0.0 | 28.3 | |
C. coli | Fresh broiler meat | 2020 | 99 | AT, BE, DE, LU, NL (5) | 1.0 | 16.2 | 84.8 | 10.1 | 67.7 | 10.1 | 5.05 |
Broiler carcases | 2020 | 76 | DE, LU, NL, RO (4) | 2.6 | 7.9 | 71.0 | 10.5 | 57.9 | 10.5 | 21.05 |
GEN: gentamicin, STR: streptomycin, NAL: nalidixic acid, CIP: ciprofloxacin, ERY: erythromycin, TET: tetracycline, CIP/ERY: combined ‘microbiological’ resistance to ciprofloxacin and erythromycin, CS: complete susceptibility to the four antimicrobial classes (ciprofloxacin/nalidixic acid, erythromycin, tetracycline and gentamicin/streptomycin), N: Total number of reporting Member States (MSs).